AbCellera Signs a Research Agreement with Bill & Melinda Gates Foundation to Accelerate Global Health Research

 AbCellera Signs a Research Agreement with Bill & Melinda Gates Foundation to Accelerate Global Health Research

AbCellera Signs a Research Agreement with Bill & Melinda Gates Foundation to Accelerate Global Health Research

Shots:

  • Bill & Melinda Gates Foundation provides $4.8M fund to AbCellera to develop Ab for infectious diseases including HIV, malaria & tuberculosis
  • The focus of the agreement is to get benefit from AbCellera’s Ab discovery technology and development of vaccines with the improvement in QoL
  • AbCellera’s single-cell screening technology is a combination of live-cell assays to develop therapies for targets such as membrane proteins, GPCRs and ion channels in multiple therapy areas. In 2017, AbCellera collaborated with Gates Foundation to discover mAb against 10 biomarkers associated with tuberculosis

Click here to read full press release/ article | Ref: AbCellera | Image: Twitter

Vartika Singh

Vartika Singh is a content writer who loves to write research articles and reports at PharmaShots. She has in-depth knowledge of the life sciences industry including the Pharma and Biotech sectors. Any articles written by her can be contacted at connect@pharmashots.com.

Related post